By contrast, in women with the nSS genotype, low ER-β expression and menopausal estrogen decreases may increase the risk of ‘usual’ type colon cancer soon after menopause, suggesting the protective role of estrogen against colon cancer as generally believed (Figure 6) [1,2,4,7,8]. This evidence concerns the gene ESR2 and malignant colon neoplasm.